FDG PET in thyroid cancer: Thyroxine or not?

Journal of Nuclear Medicine

Volumn 41, Issue 12, 2000, Pages 1996-1998

  Grunwald F ^a   Biersack, H J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THYROTROPIN; THYROXINE;

CANCER DIAGNOSIS; DRUG UPTAKE; HUMAN; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYROID CANCER; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

FLUORODEOXYGLUCOSE F18; HUMANS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROTROPIN; THYROXINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034524741     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (27)

1. The clinician and the thyroid
2. Iodide symporter gene expression in human thyroid tumors
3. - symporter gene in human thyroid tumors: A comparison study with other thyroid-specific genes
4. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas
5. Redifferentiation induced radioiodine uptake in thyroid cancer
6. Redifferentiation therapy with retinoic acid in follicular thyroid cancer
7. Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: Basics and first clinical results
8. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma
9. A comparison of T1-201 and Tc-99m-MIBI in the follow-up of differentiated thyroid carcinoma
10. Clinical utility of technetium-99m methoxyisobutylisonitrile imaging in differentiated thyroid carcinoma: Comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation
11. The thyrotropin receptor in thyroid diseases
12. Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: Immunohistochemical detection of TSH-R
13. Activating mutations of the TSH receptor in differentiated thyroid carcinoma
14. Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the beta-adrenergic receptor
15. Fluorine-18 fluorodeoxygiacose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer
16. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer
17. 99mTc-sestamibi scintigraphy in differentiated thyroid cancer
18. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer
19. Effect of in vivo thyroid hormone status on insulin signalling and GLUTI and GLUT2 glucose transport systems in rat adipocytes
20. F-18-FDG PET in autonomous goiter
21. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement
22. Primary hypothyroidism-associated TSH-secreting pituitary adenoma/hyperplasia presenting as a bleeding nasal mass and extremely elevated TSH level
23. Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: Implications for diagnosis and therapy
24. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study
25. 131)I whole body scans and elevated serum thyroglobulin levels
26. Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma
27. Chronic thyroiditis: Diffuse uptake of FDG at PET